Healthcare
Live Price
Offline$76.92
+1.83% today
1Y Change
+488.78%
Window
Jun 26, 2025 → Jun 24, 2026
Coverage: 249 bars · Jun 26, 2025 → Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Liquidia Corporation (LQDA) is a Healthcare stock with a market cap of $3.40B and listed on NASDAQ. The stock last traded around $76.92 and up 488.8% across the available one-year price window (Jun 26, 2025 → Jun 24, 2026). Baseline metrics include revenue growth of +1031.2%, EPS growth of +51.8%, a dividend yield of 0.0%. What stands out right now is revenue +1031.2%, EPS +51.8%, free cash flow +59.3% with operating margin -32.5% and ROIC -20.5%. Valuation already assumes a fairly strong business story at price/sales 21.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines LQDA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
LQDA
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
LQDA Max Drawdown
-35.66%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for LQDA and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+1031.2%
EPS Growth
+51.8%
Gross Margin
97.2%
Net Margin
-43.5%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.